Clinical trials · Iowa
Fabry Disease clinical trials in Iowa
We’re tracking 4 recruiting fabry disease studies with a site in Iowa — including Phase 2/Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Iowa
- NCT06328608RecruitingPhase 2/Phase 3
PRX-102 for children with Fabry disease
This study tests a new enzyme replacement therapy called PRX-102 for children with Fabry disease. It aims to see if the drug is safe and helps manage symptoms like pain and eye or skin changes.
Iowa City, IowaAges 2–17 - NCT05039866Enrolling by invitation
Long-term follow-up after receiving ST-920
This study checks how people are doing long after they previously received ST-920 in an earlier trial. It may help researchers understand long-term safety and outcomes from that treatment.
Iowa City, IowaAges 18 years+ - NCT00196742Recruiting
Fabry disease registry and pregnancy follow-up
This study collects health information from people with Fabry disease and specifically from pregnant people with Fabry disease. It helps researchers better understand the condition and how pregnancy affects health, using information you already experience in routine care.
Iowa City, IowaAges Any age - NCT06663358Recruiting
Safety and effectiveness of Elfabrio in Fabry disease patients
This study is for people with Fabry disease who are taking or planning to take the medication Elfabrio (pegunigalsidase alfa). It will look at how safe and effective the treatment is in real-world use.
Iowa City, IowaAges 18 years+
Where these studies are running in Iowa
Institutions with a site for the recruiting fabry disease studies listed above.
- University of Iowa · 2 studies
- University of Iowa Hospitals and Clinics · 2 studies
What taking part in a fabry disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Fabry Disease trials in other states
Common questions
- Are there fabry disease clinical trials in Iowa?
- Yes. We're currently tracking 4 recruiting fabry disease studies with a site in Iowa, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a fabry disease study in Iowa?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Iowa to take part?
- Not necessarily. These studies have a site in Iowa, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a fabry disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New fabry disease studies open in Iowa regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.